{"classes":[{"categories":[{"measurements":[{"comment":"Not enough events to calculate Median or Upper Limit.","groupId":"OG000","lowerLimit":"5.1","upperLimit":"NA","value":"NA"},{"comment":"Not enough events to calculate Median or Upper Limit.","groupId":"OG001","lowerLimit":"7.2","upperLimit":"NA","value":"NA"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"5"}],"units":"Participants"}],"description":"Duration of response is defined as the time from start of the first documentation of objective tumor response (CR or PR), according to the Modified Lugano Criteria for Response Assessment (Cheson 2007), to the first documentation of objective tumor progression or to death due to any cause, whichever comes first.","dispersionType":"95% Confidence Interval","groups":[{"description":"Participants with classic Hodgkin lymphoma","id":"OG000","title":"Classic Hodgkin Lymphoma"},{"description":"Participants with peripheral T cell lymphoma","id":"OG001","title":"PTCL"}],"paramType":"MEDIAN","populationDescription":"The full analysis set includes participants who received at least one dose of study treatment. This is a subset analysis of participants with complete response or partial response.","reportingStatus":"POSTED","timeFrame":"Up to 17.1 months","title":"DOR Per Investigator Assessment According to Modified Lugano Response Criteria","type":"SECONDARY","unitOfMeasure":"Months"}